Free Trial

Aigen Investment Management LP Invests $596,000 in MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

Aigen Investment Management LP bought a new position in MetLife, Inc. (NYSE:MET - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 7,232 shares of the financial services provider's stock, valued at approximately $596,000.

A number of other large investors have also bought and sold shares of the business. Vanguard Group Inc. boosted its position in MetLife by 3.4% in the 1st quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider's stock valued at $4,418,612,000 after buying an additional 1,974,268 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in MetLife by 22.4% in the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider's stock valued at $378,799,000 after acquiring an additional 988,666 shares during the period. Legal & General Group Plc increased its holdings in shares of MetLife by 5.4% in the second quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider's stock worth $371,993,000 after acquiring an additional 269,246 shares in the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of MetLife by 3.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 3,224,930 shares of the financial services provider's stock valued at $226,358,000 after purchasing an additional 100,782 shares in the last quarter. Finally, Bessemer Group Inc. increased its stake in MetLife by 29.7% during the 1st quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider's stock worth $157,133,000 after purchasing an additional 485,811 shares in the last quarter. 89.81% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have issued reports on MET shares. Piper Sandler upped their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 2nd. Citigroup upped their target price on MetLife from $83.00 to $89.00 and gave the company a "buy" rating in a research report on Tuesday, July 23rd. Morgan Stanley reduced their price target on MetLife from $86.00 to $85.00 and set an "overweight" rating for the company in a research note on Monday, August 19th. TD Cowen initiated coverage on MetLife in a research report on Wednesday, October 9th. They set a "buy" rating and a $97.00 price objective on the stock. Finally, Wells Fargo & Company boosted their target price on shares of MetLife from $92.00 to $93.00 and gave the company an "overweight" rating in a research report on Tuesday, November 5th. Fourteen analysts have rated the stock with a buy rating, According to data from MarketBeat.com, MetLife currently has a consensus rating of "Buy" and an average price target of $88.46.

Read Our Latest Stock Report on MetLife

MetLife Price Performance

MET traded up $0.58 during trading on Thursday, reaching $82.60. 1,965,154 shares of the company were exchanged, compared to its average volume of 3,321,865. The company's 50-day moving average is $81.30 and its two-hundred day moving average is $75.43. The company has a market cap of $57.19 billion, a price-to-earnings ratio of 16.54, a P/E/G ratio of 0.75 and a beta of 1.05. MetLife, Inc. has a 12-month low of $61.61 and a 12-month high of $86.94. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.64%. The ex-dividend date is Tuesday, November 5th. MetLife's payout ratio is 43.95%.

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines